Loading
Latest filing published 09 Jul 2021 for Evofem Biosciences, Inc., €16k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Russell Barrans, listed as senior executive, appears in our data through filings on Evofem Biosciences, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 20 May 2021 and the latest from 8 July 2021.
On the market, this insider has only ever bought: 1 purchase, €17k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants.
The latest filing, published on 9 July 2021, reports a share grant of €16k in Evofem Biosciences, Inc. The most recent open-market purchase was published on 11 June 2021, 1,956 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations